You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 7, 2025

Drugs in ATC Class A09AB


✉ Email this page to a colleague

« Back to Dashboard


Drugs in ATC Class: A09AB - Acid preparations

A09AB Market Analysis and Financial Projection

The ATC Class A09AB encompasses acid preparations used for digestive purposes, with key agents including citric acid (A09AB04), glutamic acid hydrochloride (A09AB01), betaine hydrochloride (A09AB02), and hydrochloric acid (A09AB03). These compounds play critical roles in regulating pH, enhancing digestion, and serving as preservatives in pharmaceuticals and food industries. Below is an analysis of their market dynamics and patent landscape:


Market Dynamics

Growth Drivers

  • Demand in Food & Beverage: Citric acid dominates the global acidity regulators market (valued at $7.34 billion in 2023), driven by its use in beverages, processed foods, and dairy products[4][11]. Phosphoric acid and lactic acid follow, with the latter gaining traction in yogurt and cheese production[4].
  • Pharmaceutical Applications: Citric acid is widely used in blood collection tubes, drug formulations (e.g., anticoagulants), and as an excipient. Glutamic acid hydrochloride is utilized in gastroprotective preparations[5][8].
  • Regional Expansion: Asia-Pacific leads the market due to rising populations, disposable incomes, and food industry growth in India and China. North America remains a key innovator, with companies like Cargill and ADM expanding production capacities[4][11].

Challenges

  • Raw Material Volatility: Price fluctuations in biomass, corn, and synthetic gases impact production costs for organic acids like citric acid[11].
  • Regulatory Compliance: Stricter environmental regulations on manufacturing processes and waste management increase operational costs[14].

Innovation Trends

  • Collaborative R&D: BASF and Solvay partnered in 2023 to develop advanced pH regulators for industrial applications, enhancing efficiency in sectors like agriculture and chemicals[4].
  • Eco-Friendly Solutions: Growing emphasis on bio-based acids and green chemistry to meet sustainability goals[11].

Patent Landscape

Key Technological Focus Areas

  1. Formulation Patents:
    • Citric acid patents cover applications in anticoagulants (e.g., CITRAVESCENT for renal tubular acidosis)[8], preservatives, and acidifying agents[5].
    • Grazoprevir-related patents highlight processes for stabilizing formulations using citric acid derivatives[9].
  2. AI Integration: Near-infrared spectroscopy patents (e.g., by Life Technologies and Nvidia) incorporate AI for real-time analysis of acid interactions in pharmaceuticals[2].
  3. Device-Specific Patents: Innovations in portable diagnostic tools and drug delivery systems leveraging acid preparations for pH control[2][12].

Regional Patent Activity

  • U.S. Leadership: Over 800 patents in spectroscopy and acid-based formulations, led by companies like Purdue Pharma and Cilag GmbH[2].
  • Asia-Pacific Growth: Surge in patents for citric acid extraction technologies and biodegradable formulations, particularly in China and India[11].

Strategic Insights

  • Portfolio Diversification: Companies like Kerry Group and Archer Daniels Midland focus on securing patents for multi-enzyme/acid combinations (e.g., A09AC02)[15].
  • Litigation Risks: Overlapping patents in nanotechnology and acid stabilization methods could lead to disputes, emphasizing the need for thorough freedom-to-operate analyses[6][12].

Market Outlook

The global acidity regulators market is projected to grow at a 4.81% CAGR through 2029, reaching $989.8 million for spectroscopy-linked applications[2][4]. Citric acid will remain pivotal due to its versatility, while advancements in AI-driven formulation optimization and sustainable production methods will shape future R&D. Key opportunities lie in addressing regulatory hurdles and expanding into emerging markets with tailored acid solutions[4][11].

"The integration of AI and eco-friendly manufacturing is revolutionizing acid preparation technologies, offering precision and sustainability." — ResearchAndMarkets.com[2].

References

  1. https://www.tglobaltechnology.com/product/tg-s09ab-potting-compound/
  2. https://www.globenewswire.com/news-release/2025/03/14/3043095/28124/en/Comprehensive-Near-Infrared-Spectroscopy-Patent-Landscape-Report-Reveals-Market-to-Reach-USD-989-8-Million-by-2032.html
  3. https://pubchem.ncbi.nlm.nih.gov/compound/Citric-Acid
  4. https://www.techsciresearch.com/report/acidity-regulators-market/21161.html
  5. https://go.drugbank.com/drugs/DB04272
  6. https://www.knowmade.com/patent-analytics-services/patent-report/life-sciences-patent-landscape/allogeneic-car-patent-landscape-analysis-2023/
  7. https://go.drugbank.com/drugs/DB00142
  8. https://www.rxreasoner.com/drugs/citravescent
  9. https://unitaid.org/uploads/Grazoprevir_Patent_Landscape.pdf
  10. https://www.globenewswire.com/news-release/2024/11/08/2977421/28124/en/Ammonia-Market-Global-Forecast-Report-to-2029-Featuring-Green-Ammonia-Impact-Assessment-Case-Study.html
  11. https://www.fortunebusinessinsights.com/organic-acids-market-102442
  12. https://medicinespatentpool.org/uploads/2020/04/MPP-Unitaid_Intellectual-property-report-on-long-acting-technologies.pdf
  13. https://www.globenewswire.com/news-release/2024/08/15/2930740/28124/en/Global-Battery-Energy-Storage-System-Market-Forecast-to-2029-Increasing-Opportunities-in-Rural-Electrification-Projects-Worldwide-and-Rising-Demand-for-Power-Supply-from-Data-Cente.html
  14. https://www.coherentmarketinsights.com/industry-reports/sulfamic-acid-market
  15. https://prediction.charite.de/subpages/tree.php
  16. https://www.ipcheckups.com/patent-landscape-analysis-how-to-5-steps/
  17. https://www.iiprd.com/patent-technology-landscape-analysis/

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.